IRCT2016040627260N1已完成未知
Clinical Trial on efficacy of autologous plasma therapy on clinical symptoms of Patients with Chronic Spontaneous Urticaria Compared with no treatment
Vice-chancellor for Research of Bushehr University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 90 years（—）
- 性别
- All
入选标准
- •Inclusion criteria are urticaria for more than 2 months; Age over than 15 year old; Consent to participate in the study; Negative Prick skin test for common inhalation and food allergens and normal findings in Lab data such as CBC (Complete Blood Count), ANA (Antinuclear antibody), ESR (Erythrocyte Sedimentation Rate), LFT (Liver Function Test), U/A (Urine Analysis) and S/E (Stool Exam).
- •Exclusion criteria are Pregnancy; Physical urticaria; Use of corticosteroid and immunosuppressive agents during the last 6 weeks; Use of drugs other than antihistamine and other systemic diseases.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Evaluation of clinical efficacy of autologous plasma therapy for the patients with recalcitrant atopic dermatitis and identification of plasma fraction mediating therapeutic efficacyDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanismKCT0000453Ajou University Hospital36
已完成
不适用
Does autologous platelet rich plasma help in improvement of vision in patients of retinitis pigmentosa?CTRI/2021/10/037501GSVM Medical College39
已完成
不适用
Evaluate of clinical efficacy of autologous serum therapyDiseases of the skin and subcutaneous tissueKCT0001969Ajou University Hospital50
招募中
Unknown
Study on the safety and efficacy of autologous platelet-rich plasma (PRP) in treatment of male post prostatectomy urinary incontinencepost prostatectomy urinary incontinenceJPRN-jRCTc030230395Abe Hirokazu40
招募中
Unknown
Study on the safety and efficacy of autologous platelet-rich plasma (PRP) in treatment of female stress urinary incontinencestress urinary incontinenceJPRN-jRCTc030230394Abe Hirokazu40